首页 | 本学科首页   官方微博 | 高级检索  
检索        

参芪扶正注射液对人乳腺癌MDA-MB-231细胞增殖和凋亡的影响
引用本文:安松林,丁治国,解云婧,丁磊,周柯鑫,滕占庆,史晓光,李乃卿.参芪扶正注射液对人乳腺癌MDA-MB-231细胞增殖和凋亡的影响[J].中国实验方剂学杂志,2016,22(12):139-143.
作者姓名:安松林  丁治国  解云婧  丁磊  周柯鑫  滕占庆  史晓光  李乃卿
作者单位:首都医科大学附属北京世纪坛医院, 北京 100038,北京中医药大学 东直门医院, 北京 100700,北京市门头沟区中医医院, 北京 102300,首都医科大学附属北京世纪坛医院, 北京 100038,北京中医药大学 东直门医院, 北京 100700,北京中医药大学 东直门医院, 北京 100700,北京中医药大学 东直门医院, 北京 100700,北京中医药大学 东直门医院, 北京 100700
基金项目:北京中医药大学中青年教师资助项目(2011JYB22JS-008)
摘    要:目的:研究参芪扶正注射液对基底细胞样(basal-like型)乳腺癌MDA-MB~(-2)31细胞增殖和凋亡的影响,探讨参芪扶正注射液对三阴性乳腺癌的治疗作用机制。方法:体外培养人乳腺癌MDA-MB~(-2)31细胞,将其分为参芪扶正注射液组和空白组。采用噻唑蓝(MTT)比色法分别于24,48,72 h检测参芪扶正注射液对人乳腺癌MDA-MB~(-2)31细胞增殖的影响。采用流式细胞术(FCM)测定细胞周期分布和凋亡情况。实时荧光定量PCR(Real-time PCR)和免疫印迹(Western blot)检测参芪扶正注射液对MDA-MB~(-2)31细胞p53正向细胞凋亡调控因子(PUMA)表达的影响。结果:参芪扶正注射液可抑制MDA-MB~(-2)31细胞增殖,高浓度者抑制作用强,即呈现浓度依赖性,体外培养48 h时抑制作用最显著。参芪扶正注射液将MDA-MB~(-2)31细胞阻滞于细胞周期的S期,进而诱导MDA-MB~(-2)31细胞凋亡。Real-time PCR和Western blot发现参芪扶正注射液可上调MDA-MB~(-2)31细胞PUMA蛋白和基因表达。结论:参芪扶正注射液可显著抑制人乳腺癌MDA-MB~(-2)31细胞增殖,导致细胞周期阻滞,诱导细胞凋亡,其机制可能与上调PUMA基因有关。

关 键 词:参芪扶正注射液  basal-like型乳腺癌  MDA-MB-231细胞  p53正向细胞凋亡调控因子
收稿时间:1/7/2016 12:00:00 AM

Effects of Shenqi Fuzheng Injection on Proliferation and Apoptosis of Human Breast Cancer MDA-MB-231 Cells
AN Song-lin,DING Zhi-guo,XIE Yun-jing,DING Lei,ZHOU Ke-xin,TENG Zhan-qing,SHI Xiao-guang and LI Nai-qing.Effects of Shenqi Fuzheng Injection on Proliferation and Apoptosis of Human Breast Cancer MDA-MB-231 Cells[J].China Journal of Experimental Traditional Medical Formulae,2016,22(12):139-143.
Authors:AN Song-lin  DING Zhi-guo  XIE Yun-jing  DING Lei  ZHOU Ke-xin  TENG Zhan-qing  SHI Xiao-guang and LI Nai-qing
Institution:Beijing Shijitan Hospital, CMU, Beijing 100038, China,Beijing Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing 100700, China,Beijing Mentougou Hospital of Traditional Chinese Medicine, Beijing 102300, China,Beijing Shijitan Hospital, CMU, Beijing 100038, China,Beijing Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing 100700, China,Beijing Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing 100700, China,Beijing Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing 100700, China and Beijing Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing 100700, China
Abstract:Objective: To study the effects of Shenqi Fuzheng injection on proliferation and apoptosis of basal-like type human breast cancer MDA-MB-231 cells, and investigate the treatment mechanism of Shenqi Fuzheng injection for triple negative breast cancer. Method: The human breast cancer MDA-MB-231 cells cultured in vitro were divided into Fuzheng injection groups (six groups with different concentrations of Shenqi Fuzheng injection) and blank group. Methyl thiazolyl tetrazolium (MTT) assay was used to detect the effect of Shenqi Fuzheng injection on proliferation of MDA-MB-231 cells at 24, 48 and 74 h. Flow cytometry (FCM) was used to detect the cell cycle distribution and apoptosis of MDA-MB-231 cells. Real-time PCR and Western blot assay were used to detect the effect of Shenqi Fuzheng injection on p53 up-regulated modulators of apoptosis (PUMA) in MDA-MB-231 cells. Result: Shenqi Fuzheng injection could inhibit the proliferation of MDA-MB-231 cells in a concentration-dependent manner, and the inhibitory effect was most obvious at 48 h in vitro culture. Shenqi Fuzheng injection blocked cell cycle at S phase of the MDA-MB-231 cells, and thus induced apoptosis of MDA-MB-231 cells. Real-time PCR and Western blot assay showed that Shenqi Fuzheng injection could up-regulate PUMA expression of MDA-MB-231 cells. Conclusion: Shenqi Fuzheng injection can significantly inhibit proliferation and block cell cycle at S phase of the MDA-MB-231 cells, thus induce apoptosis of the cells, and the mechanism may be associated with up-regulating PUMA mRNA expression.
Keywords:Shenqi Fuzheng injection  basal-like type breast cancer  MDA-MB-231 cells  p53 up-regulated modulators of apoptosis
本文献已被 CNKI 等数据库收录!
点击此处可从《中国实验方剂学杂志》浏览原始摘要信息
点击此处可从《中国实验方剂学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号